Abstract
Treatment of Parkinson’s disease (PD) is based on the principle that the deficiency of dopamine in the brain can be countered by administering its natural precursor (levodopa). Apart from this we discussed other oral therapies which can be commenced as monotherapy or adjunctive therapies including MAO-B Inhibitors, COMT Inhibitors, NMDA receptor antagonist, Adenosine A2A receptor antagonist and Dopamine agonists. We explained the rationale of early treatment, strategy of initial treatment, the significance of continuous dopaminergic stimulation, strategy of treatment for advanced PD, and deep brain stimulation as a surgical treatment. We also discussed the side effects and other issues arising from administration of various therapies. We compared various device assisted therapies especially in advanced PD cases and tried to shed some light on choice of each of them under various circumstances. We touch based newer therapies and strategies which are still under investigation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
